Score study report 12: Development of venous collaterals in the score study

Retina

Volumn 33, Issue 2, 2013, Pages 287-295

  Weinberg, David V ^a   Wahle, Aimee E ^b   Ip, Michael S ^c   Scott, Ingrid U ^d   Van Veldhuisen, Paul C ^b   Blodi, Barbara A ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

branch retinal vein occlusion; central retinal vein occlusion; corticosteroid; intravitreal pharmacotherapy; venous collateral; visual acuity

Indexed keywords

TRIAMCINOLONE ACETONIDE;

AGE; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; COLLATERAL CIRCULATION; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTIC DISK; OUTCOME ASSESSMENT; RETINA MACULA EDEMA; VENOUS COLLATERAL; VISUAL ACUITY;

COLLATERAL CIRCULATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; OPTIC DISK; RETINAL VEIN; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 84873405256     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318263d106     Document Type: Article

References (25)

1. Blinder KJ, Khan JA, Giangiacomo J, Ide CH. Optociliary veins and visual prognosis after central retinal vein occlusion. Ann Ophthalmol 1989;21:192-194, 197.
2. Fuller JJ, Mason JO, White MF, et al. Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion. Arch Ophthalmol 2003; 121:332-336.
3. Priluck IA, Robertson DM, Hollenhorst RW. Long-term followup of occlusion of the central retinal vein in young adults. Am J Ophthalmol 1980;90:190-202.
4. Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 2011;118:119-133.e1-e2.
5. Cunningham MA, Edelman JL, Kaushal S. Intravitreal steroids for macular edema: The past, the present, and the future. Surv Ophthalmol 2008;53:139-149.
6. Protocol for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study [computer program]. Version 7.0. 24-47; 54-65. Bethesda, MD: National Eye Institute. NTIS order number PB2008-113743.
7. Manual of Policies and Procedures (MOPP) for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study [computer program]. Version 4.0. Bethesda, MD: National Eye Institute; 2008. NTIS order number PB2008-106870.
8. Scott IU, VanVeldhuisen PC, Oden NL, et al. SCORE Study report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009;116:504-512.
9. Ip MS, Scott IU, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-1114.
10. Scott IU, Ip MS, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-1128.
11. Fundus Photograph Reading Center Imaging Procedures for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study. Bethesda, MD: National Eye Institute. NTIS order number PB2009-113740.
12. Danis RP, Moorthy RS, Savage J. Microhemodynamics of retinal collateral vessel formation. Med Hypotheses 1995;44: 103-109.
13. Kohner EM, Dollery CT, Shakib M, et al. Experimental retinal branch vein occlusion. Am J Ophthalmol 1970;69:778-825.
14. Takahashi K, Muraoka K, Kishi S, Shimizu K. Formation of retinochoroidal collaterals in central retinal vein occlusion. Am J Ophthalmol 1998:126:91-99.
15. Schatz H, Green WR, Talamo JH, et al. Clinicopathologic correlation of retinal to choroidal venous collaterals of the optic nerve head. Ophthalmology 1991;98:1287-1293.
16. Giuffrè G, Palumbo C, Randazzo-Papa G. Optociliary veins and central retinal vein occlusion. Br J Ophthalmol 1993;77: 774-777.
17. Glacet-Bernard A, Coscas G, Chabanel A, et al. Prognostic factors for retinal vein occlusion: Prospective study of 175 cases. Ophthalmology 1996;103:551-560.
18. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990;110: 118-123.
19. Sinclair SH, Gragoudas ES. Prognosis for rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol 1979; 63:735-743.
20. Hayreh SS, Hayreh MS. Hemi-central retinal vein occulsion. Pathogenesis, clinical features, and natural history. Arch Ophthalmol 1980;98:1600-1609.
21. Pieris SJ, Hill DW. Collateral vessels in branch retinal vein occlusion. Trans Ophthalmol Soc U K 1982;102:178-181.
22. Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007; 144:864-871.
23. Chang LK, Spaide RF, Klancnik JM, et al. Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Retina 2011;31:821-828.
24. Spaide RF, Chang LK, Klancnik JM, et al. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 2009;147:298-306.
25. Ip MS, Oden NL, Scott IU, et al. SCORE Study report 3: Study design and baseline characteristics. Ophthalmology 2009;116: 1770-1777.e1.